Fermented Garlic Lettuce Powder and Cognitive Function in Adults With Mild Cognitive Impairment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-19

Study Completion Date

2026-01-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

"This study aims to investigate the cognitive and psychological changes in adults with mild cognitive impairment (K-MoCA scores between 16 and 23) following daily consumption of fermented garlic lettuce powder for 2 months

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia

NCT01402102

Hyperlipidemia

COMPLETED PHASE2/PHASE3

Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids

NCT01735149

Hyperlipidemia

UNKNOWN PHASE2/PHASE3

Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health

NCT06870136

Cognitive Decline

RECRUITING

Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment

NCT06083350

Mild Cognitive Impairment Alzheimer Disease

ACTIVE_NOT_RECRUITING NA

Identifying the Anti-Blood-Clotting Compounds in Garlic

NCT00200785

Arteriosclerosis Intracranial Arteriosclerosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild Cognitive Impairment (MCI)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants with mild cognitive impairment (K-MoCA scores 16-23) will be randomly assigned to either the intervention group receiving fermented garlic lettuce powder daily for 2 months or to a control group. Cognitive and psychological outcomes will be assessed at baseline and at the end of the 2-month intervention. Outcome assessors will be blinded to group allocation, and the study will be conducted as a single-center, investigator-initiated, parallel-group, randomized controlled trial.

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

except for one assessor who will have access to group assignments

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fermented Garlic Lettuce Powder

Participants receive fermented garlic lettuce powder, administered orally as three tablets per day for 2 months (total of 180 tablets).

Group Type EXPERIMENTAL

Garlic Lettuce Fermented Powder

Intervention Type DIETARY_SUPPLEMENT

The Garlic Lettuce Fermented Powder tablets (intervention group) are taken 3 tablets daily for 2 months, totaling 180 tablets

Placebo Tablet

Participants take 1 placebo tablet daily for 2 months, totaling 60 tablets

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Participants take 1 placebo tablet daily for 2 months, totaling 60 tablets

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Garlic Lettuce Fermented Powder

The Garlic Lettuce Fermented Powder tablets (intervention group) are taken 3 tablets daily for 2 months, totaling 180 tablets

Intervention Type DIETARY_SUPPLEMENT

Placebo

Participants take 1 placebo tablet daily for 2 months, totaling 60 tablets

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 19 years or older with K-MoCA scores between 16 and 23.
* Individuals with sufficient vision and hearing to participate in the study without difficulty.
* Participants who are currently taking medications or receiving treatments that may affect cognition and are able to maintain the same dosage and regimen throughout the study period.
* Individuals who voluntarily agree to participate in the study and provide written informed consent.

Exclusion Criteria

* Individuals who have undergone vascular-related surgery within the past 6 months or gastrointestinal surgery that may affect absorption of the study product (excluding simple appendectomy or hernia repair).
* Individuals with a clinically significant history of hypersensitivity to medications or dietary supplements.
* Individuals with a history of alcohol or drug abuse.
* Individuals unable to communicate effectively.
* Individuals who have participated in more than two dietary supplement studies or clinical trials within the current year, or within the past 6 months.
* Individuals deemed unable to participate safely or effectively in the study by the investigator.

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No